These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19412500)

  • 21. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
    Ballard C; Waite J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: a systematic review].
    Zuidema SU; van Iersel MB; Koopmans RT; Verhey FR; Olde Rikkert MG
    Ned Tijdschr Geneeskd; 2006 Jul; 150(28):1565-73. PubMed ID: 16886695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits and harms of atypical antipsychotics for agitation in adults with dementia.
    Farlow MR; Shamliyan TA
    Eur Neuropsychopharmacol; 2017 Mar; 27(3):217-231. PubMed ID: 28111239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clozapine versus other atypical antipsychotics for schizophrenia.
    Asenjo Lobos C; Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Leucht S
    Cochrane Database Syst Rev; 2010 Nov; (11):CD006633. PubMed ID: 21069690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis.
    Yunusa I; Rashid N; Demos GN; Mahadik BS; Abler VC; Rajagopalan K
    Adv Ther; 2022 May; 39(5):1993-2008. PubMed ID: 35247186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical antipsychotics in the treatment of psychotic symptoms in Alzheimer's disease: a systematic review.
    Vinaşi R; Buciuta A; Coman HG
    Int Clin Psychopharmacol; 2021 Jul; 36(4):169-180. PubMed ID: 33902085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olanzapine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia.
    Van Leeuwen E; Petrovic M; van Driel ML; De Sutter AI; Vander Stichele R; Declercq T; Christiaens T
    Cochrane Database Syst Rev; 2018 Apr; 3(3):CD007726. PubMed ID: 29605970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on neuropsychiatric symptoms of dementia: antipsychotic use.
    Kalapatapu RK; Schimming C
    Geriatrics; 2009 May; 64(5):10-8. PubMed ID: 19435390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotics for treatment of delirium in hospitalised non-ICU patients.
    Burry L; Mehta S; Perreault MM; Luxenberg JS; Siddiqi N; Hutton B; Fergusson DA; Bell C; Rose L
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD005594. PubMed ID: 29920656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of atypical antipsychotics in the management of schizophrenia.
    Campbell M; Young PI; Bateman DN; Smith JM; Thomas SH
    Br J Clin Pharmacol; 1999 Jan; 47(1):13-22. PubMed ID: 10073734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.
    Maust DT; Kim HM; Seyfried LS; Chiang C; Kavanagh J; Schneider LS; Kales HC
    JAMA Psychiatry; 2015 May; 72(5):438-45. PubMed ID: 25786075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical antipsychotics for the treatment of delirious elders.
    Ozbolt LB; Paniagua MA; Kaiser RM
    J Am Med Dir Assoc; 2008 Jan; 9(1):18-28. PubMed ID: 18187109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Typical and atypical antipsychotics in bipolar depression.
    Gao K; Gajwani P; Elhaj O; Calabrese JR
    J Clin Psychiatry; 2005 Nov; 66(11):1376-85. PubMed ID: 16420074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization.
    Jin H; Shih PA; Golshan S; Mudaliar S; Henry R; Glorioso DK; Arndt S; Kraemer HC; Jeste DV
    J Clin Psychiatry; 2013 Jan; 74(1):10-8. PubMed ID: 23218100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008559. PubMed ID: 28791693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical antipsychotics in elderly patients with dementia or schizophrenia: review of recent literature.
    Jeste DV; Dolder CR; Nayak GV; Salzman C
    Harv Rev Psychiatry; 2005; 13(6):340-51. PubMed ID: 16373328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological interventions for the treatment of disordered and problem gambling.
    Dowling N; Merkouris S; Lubman D; Thomas S; Bowden-Jones H; Cowlishaw S
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD008936. PubMed ID: 36130734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.
    Miller DS; Yatham LN; Lam RW
    J Clin Psychiatry; 2001 Dec; 62(12):975-80. PubMed ID: 11780879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review.
    Seitz DP; Gill SS; Herrmann N; Brisbin S; Rapoport MJ; Rines J; Wilson K; Le Clair K; Conn DK
    Int Psychogeriatr; 2013 Feb; 25(2):185-203. PubMed ID: 23083438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.